Gull Laboratories, Inc.
United StatesFDA 510(k) applicant, unverified
- Devices
- 57
What Gull Laboratories, Inc. makes
Gull Laboratories, Inc. manufactures in vitro diagnostic tests for detecting specific antibodies and antigens, including ELISA-based assays for CMV, toxoplasmosis, rubella, respiratory syncytial virus, herpes simplex virus (HSV), Chagas disease, varicella-zoster virus (VZV), Lyme disease, and Epstein-Barr virus (EBV). The company also produces the DetectaDot System 2000, a rapid lateral flow test for toxoplasmosis and CMV IgG.
These devices are regulated under the FDA’s 510(k) pathway, with most classified as Class I or Class II in vitro diagnostic devices. The company is based in the United States.
Catalogue
Search and filter all 57 devicesShowing 1-50 of 57
Frequently asked questions
How many devices does Gull Laboratories, Inc. have in the registry?
The registry currently lists 57 devices for Gull Laboratories, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Gull Laboratories, Inc.'s devices?
Among its 50 most recently registered devices, Gull Laboratories, Inc. has devices listed in FDA 510(k) (50 devices).
What risk classes do Gull Laboratories, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Gull Laboratories, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Gull Laboratories, Inc. in the registry?
The most recently registered devices listed for Gull Laboratories, Inc. include CMV IGM ELISA TEST, DETECTADOT SYSTEM 2000 TOXO IGG TEST, RUBELLA IGG ELISA TEST and ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODY TEST.